A cross-sectional comparison of three self-reported functional indices in scleroderma

Rheumatology

Volumn 42, Issue 6, 2003, Pages 732-738

  Smyth, A E ^b   MacGregor, A J ^a   Mukerjee, D ^b   Brough, G M ^b   Black, C M ^b   Denton, C P ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Functional indices; HAQ DI; Scleroderma; UKFS

Indexed keywords

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HAND FUNCTION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE FUNCTION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCLERODERMA; SCORING SYSTEM; SELF REPORT; SYMPTOMATOLOGY; VISUAL ANALOG SCALE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISABILITY; HAND; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; STATISTICAL MODEL; SYSTEMIC SCLEROSIS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HAND; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 0038264246     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg145     Document Type: Article

References (22)

1. Medsger TA Jr. Systemic sclerosis, eosinophilic fasciitis and calcinosis. In: McCarthy DJ, ed. Arthritis and allied conditions, 10th edn. Philadelphia: Lea & Febiger, 1985:994-1036.
2. Altman RD, Medsger TA Jr, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
3. Abu-Shakra M, Lee P. Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 1995;22:2100-2.
4. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660-5.
5. Pope JE, Bellamy N. Outcome measures in scleroderma clinical trials. Semin Arthritis Rheum 1993;23:22-33.
6. Clements PJ, Wong WK, Hurwitz EL et al. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001;44:653-61.
7. Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334:296-302.
8. Fries JF, Spitz P, Kraines RG, Homan HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23:137-45.
9. Poole JL, Steen VD. The use of the HAQ to determine physical disability in SSc. Arthritis Care Res 1991;4:27-31.
10. Steen VD, Medsger TA. The value of the HAQ and special patient generated scales to demonstrate change in SSc patients over time. Arthritis Rheum 1997;40:1984-91.
11. Silman A, Akesson A, Newman J. Assessment of functional ability in patients with SSc: a proposed new disability assessment instrument. J Rheumatol 1998; 25:79-83.
12. Subcommittee for Scleroderma Criteria of the ARA Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of scleroderma. Arthritis Rheum 1980;23:581-90.
13. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score in scleroderma. J Rheumatol 1995;22:1281-5.
14. Brennan P, Silman A, Black C et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. Br J Rheumatol 1993;32:357-61.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7, 403-7.
16. Kaye SA, Siraj QH, Agnew J, Hilson A, Black CM. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method. J Rheumatol 1996;23:297-301.
17. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 1989; 110:256-66.
18. Pincus T, Brooks RH, Callahan LF. Prediction of longterm mortality in patients with rheumatoid arthritis. Ann Intern Med 1994;120:26-34.
19. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 1995;8:189-93.
20. Herrick A, Rooney B, Finn J, Silman A. Lack of relationship between functional ability and skin score in patients with SSc. J Rheumatol 2001;28:292-5.
21. Vayssairat M. Preventive effect of an oral prostacyclin analogue, beraprostsodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes. J Rheumatol 1999;26:2173-8.
22. Karras DJ. Statistical methodology: II. Reliability and validity assessment in study design, Part B. Acad Emerg Med 1997;4:144-7.